Skip to main content
SpringerLink
Log in

TAVR Vs. SAVR in Intermediate-Risk Patients: What Influences Our Choice of Therapy

  • Interventional Cardiology (SR Bailey, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To determine what influences patients and physicians to choose between transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) in intermediate-surgical-risk patients with severe, symptomatic aortic stenosis.

Recent Findings

Advances in transcatheter valve technology, techniques, and trials demonstrating non-inferiority compared to surgical aortic valve replacement (SAVR) have led to expanded eligibility of transcatheter aortic valve replacement (TAVR) to both intermediate-risk patients in clinical practice and low-risk patients in pivotal trials. Since lower-risk individuals tend to be younger and good operative candidates, concerns of valve durability, procedure-related morbidity, and patient survivability require careful consideration. Results from the PARTNER II intermediate risk trials and SURTAVI trials have given us insight into the benefits and potential risks of both treatment modalities.

Summary

In this article, we review the brief yet remarkable history of TAVR and discuss its role in the treatment of intermediate-surgical-risk patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–8.

    Article  PubMed  Google Scholar 

  2. Cribier A. The development of transcatheter aortic valve replacement (TAVR). Glob Cardiol Sci Pract. 2016;2016(4):e201632.

    PubMed  PubMed Central  Google Scholar 

  3. Grover FL, Vemulapalli S, Carroll JD, Edwards FH, Mack MJ, Thourani VH, et al. 2016 Annual Report of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. J Am Coll Cardiol. 2017;69(10):1215–30.

    Article  PubMed  Google Scholar 

  4. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Fleisher LA, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;70:252–89.

    Article  PubMed  Google Scholar 

  5. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.

    Article  CAS  PubMed  Google Scholar 

  6. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.

    Article  CAS  PubMed  Google Scholar 

  7. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686–95.

    Article  CAS  PubMed  Google Scholar 

  8. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385:2477–84.

    Article  PubMed  Google Scholar 

  9. • Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374:1609–20. This study demonstrated that among patients with symptomatic severe AS who are intermediate-risk surgical candidates, TAVR was noninferior to surgical AVR with respect to all-cause mortality and disabling stroke at 2 years.

    Article  CAS  PubMed  Google Scholar 

  10. • Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017;376:1321–31. The SURTAVI trial concluded that TAVR was non-inferior to SAVR with respect to all-cause mortality and disabling stroke at 2 years in patients with severe, symptomatic AS at intermediate surgical risk. SAVR was associated with a marginally higher peri-operative stroke rate while TAVR was associated with a modest increase in hospitalizations related to aortic valvular disease at 2 years.

    Article  PubMed  Google Scholar 

  11. • Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387:2218–25. In the Sapien 3 observational study, TAVR with SAPIEN 3 was associated with low mortality, strokes, and regurgitation at 1 year in intermediate-risk patients with severe aortic stenosis.

    Article  PubMed  Google Scholar 

  12. Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation. 2009;119:1034–48.

    Article  PubMed  Google Scholar 

  13. Arora S, Ramm CJ, Misenheimer JA, Vavalle JP. Early transcatheter valve prosthesis degeneration and future ramifications. Cardiovasc Diagn Ther. 2017;7(1):1–3.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Joshi V, Prosser K, Richens D, et al. Early prosthetic valve degeneration with Mitroflow aortic valves: determination of incidence and risk factors†. Interact Cardiovasc Thorac Surg. 2014;19:36–40.

    Article  PubMed  Google Scholar 

  15. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg. 2005;79:1072–80.

    Article  PubMed  Google Scholar 

  16. Roselli EE, Smedira NG, Blackstone EH. Failure modes of the Carpentier-Edwards pericardial bioprosthesis in the aortic position. J Heart Valve Dis. 2006;15(3):421–7. discussion 427-8

    PubMed  Google Scholar 

  17. Martin C, Sun W. Comparison of transcatheter aortic valve and surgical bioprosthetic valve durability: a fatigue simulation study. J Biomech. 2015;48(12):3026–34.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Barbanti M, Petronio AS, Ettori F, Latib A, Bedogni F, de Marco F, et al. 5-year outcomes after transcatheter aortic valve implantation with CoreValve prosthesis. JACC Cardiovasc Interv. 2015;8:1084–91.

    Article  PubMed  Google Scholar 

  19. Dvir D, Webb JG, Bleiziffer S, Pasic M, Waksman R, Kodali S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014;312(2):162–70.

    Article  CAS  PubMed  Google Scholar 

  20. Abdel-Wahab M, Zahn R, Horack M, Gerckens U, Schuler G, Sievert H, et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome: results from the German transcatheter aortic valve interventions registry. Heart. 2011;97:899–906.

    Article  PubMed  Google Scholar 

  21. Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, et al. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol. 2013;112:272–9.

    Article  PubMed  Google Scholar 

  22. Adams DH, Popma JJ, Reardon MJ. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;371:967–8.

    Article  PubMed  Google Scholar 

  23. Ghanem A, Muller A, Nahle CP, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010;55:1427–32.

    Article  PubMed  Google Scholar 

  24. Kahlert P, Knipp SC, Schlamann M, Thielmann M, al-Rashid F, Weber M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121:870–8.

    Article  PubMed  Google Scholar 

  25. Makkar RR, Fontana G, Søndergaard L. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2016;374:1591–2.

    PubMed  Google Scholar 

  26. Chakravarty T, Søndergaard L, Friedman J, de Backer O, Berman D, Kofoed KF, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 2017;389:2383–92.

    Article  PubMed  Google Scholar 

  27. Rodés-Cabau J, Masson JB, Welsh RC, Garcia del Blanco B, Pelletier M, Webb JG, et al. Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: the ARTE (aspirin versus aspirin + clopidogrel following transcatheter aortic valve implantation) randomized clinical trial. JACC Cardiovasc Interv. 2017;10:1357–65.

    Article  PubMed  Google Scholar 

  28. Piayda K, Zeus T, Sievert H, Kelm M, Polzin A. Subclinical leaflet thrombosis. Lancet. 2018;391(10124):937–8.

    Article  PubMed  Google Scholar 

  29. Siontis GC, Jüni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64(2):129–40.

    Article  PubMed  Google Scholar 

  30. Fadahunsi OO, Olowoyeye A, Ukaigwe A, Li Z, Vora AN, Vemulapalli S, et al. Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT registry. JACC Cardiovasc Interv. 2016;9(21):2189–99.

    Article  PubMed  Google Scholar 

  31. Wilczek K, Reguła R, Bujak K, Chodór P, Długaszek M, Gąsior M. Conduction disturbances after transcatheter aortic valve implantation procedures - predictors and management. Postepy Kardiol Interwencyjnej. 2016;12(3):203–11.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Baylor University Medical Center, Dallas, TX, USA

    Sasha Still

  2. Department of Cardiology, The Heart Hospital Baylor Plano, 4716 Alliance Blvd Pavilion 2 Suite 300, Plano, TX, 75093, USA

    Molly Szerlip

  3. Department of Cardiothoracic Surgery, The Heart Hospital Baylor Plano, Plano, TX, USA

    Michael Mack

Authors
  1. Sasha Still
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Molly Szerlip
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Mack
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Molly Szerlip.

Ethics declarations

Conflict of Interest

Sasha Still has no conflict of interest.

Molly Szerlip is a consultant and speaker for Edwards Life Sciences, Medtronic Vascular, and Boston Scientific.

Michael Mackis a co-Principal Investigator for Clinical trials for Edwards Lifesciences, Abbott Vascular, and Medtronic, Inc. (all uncompensated).

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Interventional Cardiology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Still, S., Szerlip, M. & Mack, M. TAVR Vs. SAVR in Intermediate-Risk Patients: What Influences Our Choice of Therapy. Curr Cardiol Rep 20, 82 (2018). https://doi.org/10.1007/s11886-018-1026-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-018-1026-3

Keywords

Search

Navigation